BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 3471370)

  • 1. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 2. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

  • 3. [The myelodysplastic syndrome based on our cases].
    Bozóky G; Farkas L; Serényi P; Biliczki F
    Orv Hetil; 1986 Aug; 127(33):1993-8. PubMed ID: 3466134
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelodysplastic syndromes: natural history and features of prognostic importance.
    Mufti GJ; Galton DA
    Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphological changes in peripheral blood and bone marrow in patients with myelodysplastic syndromes].
    Mariańska B; Apel D; Maj S
    Acta Haematol Pol; 1991; 22(1):48-53. PubMed ID: 1823967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
    Di Giovanni S; Giallonardo P; Costa MP; Carducci P
    Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinico-haematological characteristics in Pakistani patients of primary myelodysplastic syndrome according to World Health Organization classification.
    Ehsan A; Aziz M
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):232-6. PubMed ID: 20392397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
    Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J
    Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
    Lipshitz J; Limaye S; Patel D
    Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
    Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
    Sarycheva TG; Tsvetaeva NV; Kozinets GI
    Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?
    Ohyashiki K; Yokoyama K; Kimura Y; Ohyashiki JH; Ito T; Kuratsuji T; Komatsumoto S; Nara M; Toyama K
    Leukemia; 1993 Feb; 7(2):338-40. PubMed ID: 8426488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transmission ultrastructure in the study of acquired refractory anemias].
    Woessner S; Lafuente R; Florensa L; Vilá RM; Sans-Sabrafen J
    Sangre (Barc); 1986; 31(1):40-56. PubMed ID: 3458311
    [No Abstract]   [Full Text] [Related]  

  • 15. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
    Piguet D; Schmidt PM; Delacrétaz F; Mermillod B
    Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
    Oguma S; Yoshida Y; Uchino H; Maekawa T
    Cancer Res; 1987 Jul; 47(13):3599-602. PubMed ID: 3581090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndromes: current diagnosis and classification].
    Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
    Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum proteomics in patients with RAEB myelodysplastic syndromes].
    Zhong LY; Liu TH; Li YQ; Geng SX; Lu ZS; Weng JY; Wu SJ; Luo CW; Du X
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Sep; 29(9):1799-801. PubMed ID: 19778794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clarification of possible anemia].
    Uprichard J; Bain BJ
    Praxis (Bern 1994); 2009 Dec; 98(24):1453-5. PubMed ID: 19953471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.